86 results
8-K
EX-99.1
VBIVQ
VBI Vaccines Inc
2 Aug 24
VBI Vaccines Provides an Update on its Restructuring Proceedings
4:05pm
the listing qualifications department staff of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that its common shares will be delisted from
8-K
VBIVQ
VBI Vaccines Inc
2 Aug 24
VBI Vaccines Provides an Update on its Restructuring Proceedings
4:05pm
or Standard; Transfer of Listing
On July 30, 2024, the Company received a letter (the “Delisting Notice”) from the listing qualifications department staff
8-K
VBIVQ
VBI Vaccines Inc
24 May 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
.
On May 24, 2024, VBI Vaccines Inc. (the “Company”) received a letter (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market
8-K
EX-1.1
VBIVQ
VBI Vaccines Inc
15 May 24
VBI Vaccines Reports First Quarter 2024 Financial Results
4:18pm
. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
(oo) U.S. Real Property Holding Corporation
424B5
VBIVQ
VBI Vaccines Inc
15 May 24
Prospectus supplement for primary offering
4:16pm
.
Nasdaq Minimum Bid Price Requirement
On November 1, 2023, we received a letter from the Listing Qualifications Department of Nasdaq indicating … .
On November 1, 2023, we received a letter from the Listing Qualifications Department of Nasdaq indicating that, based upon the closing bid price
8-K
dq05ypi
1 May 24
Other Events
4:15pm
8-K
EX-10.1
qmsgh05p2edy3du8p
11 Apr 24
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:07pm
424B5
yk3nzslxnw5nj2jciez5
11 Apr 24
Prospectus supplement for primary offering
9:06am
8-K
1xxitt
3 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
424B5
hzyjpt
7 Jul 23
Prospectus supplement for primary offering
5:25pm
424B5
d0mrbz aauiyhq84pw
7 Jul 23
Prospectus supplement for primary offering
5:20pm
8-K
EX-1.1
8khbt6st5el5 q1r84jq
6 Jul 23
VBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common Shares and Warrants
6:47pm
8-K
EX-4.1
bucfgr 49
6 Jul 23
VBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common Shares and Warrants
6:47pm